Organization · Venture Studio
UpStart Life Sciences Capital
UpStart Life Sciences Capital is a venture capital firm based in Salt Lake City, Utah, specializing in seed and early-stage investments in healthcare companies derived from university technologies. The firm adopts a venture studio model, co-founding and incubating companies alongside licensing university intellectual property.
Overview
What UpStart Life Sciences Capital does
What UpStart Life Sciences Capital is
UpStart Life Sciences Capital is a venture capital firm based in Salt Lake City, Utah, specializing in seed and early-stage investments in healthcare companies derived from university technologies. The firm adopts a venture studio model, co-founding and incubating companies alongside licensing university intellectual property.
How it participates in the startup ecosystem
The current public profile supports funder and program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Studio
- Founded
- Founded in 2009
- Approximate age
- About 17 years
- Structured capabilities
- Funder · Program host
- Last reviewed
- March 28, 2026
What Venture studio means
A venture studio is an organization that systematically creates new startups by generating or sourcing ideas, validating them, building early products, recruiting founders or operators, providing shared resources, and retaining meaningful equity in the companies it helps create.
Open the glossary entryOfficial channels
Find UpStart Life Sciences Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
UpStart Life Sciences Capital as a funder
Investment thesis
UpStart Life Sciences Capital focuses on creating and managing innovative life science companies from university-derived technologies, emphasizing early-stage investments in healthcare.
Focus narrative
UpStart Life Sciences Capital primarily invests in seed and early-stage healthcare opportunities, including medical devices, drug delivery systems, diagnostics, and biopharma products and platforms. The firm emphasizes the creation of value through the formation and management of innovative life science companies, rather than traditional venture capital investments in existing companies.
Value beyond capital
UpStart Life Sciences Capital adds value to its portfolio companies through its expertise in company formation and management, leveraging university partnerships to access cutting-edge technologies and research. The firm’s focus on early-stage investments allows it to guide companies from inception to growth, ensuring alignment with market needs and technological advancements.
Focus and fit
- Stages
- Seed
- Sectors
- Healthcare · Biotech · Medical Devices · Diagnostics
- Regions
- North AmericaUnited States
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 12
Portfolio context
Notable portfolio companies include Sera Prognostics, Inc., a preterm birth predictor based on serum proteomics; MedCatheters, Inc.; Q Therapeutics; JST Research; Elute, Inc., which focuses on drug delivery; and PhotoPharmics, Inc., known for light-based therapies. Other companies in their portfolio include Veritract, Complexa, Inc., XableCath, NeuroAdjuvants, ContraDyn, Inc., MedAnalytics, Inc., and Catheter Connections, Inc.
Capability profile
UpStart Life Sciences Capital as a program host
Program thesis
UpStart Life Sciences Capital focuses on investing in seed and early-stage healthcare companies based on breakthrough technologies developed at major research universities, particularly in Utah and neighboring states.
Focus narrative
UpStart Life Sciences Capital primarily invests in seed and early-stage healthcare opportunities, including medical devices, drug delivery systems, diagnostics, and biopharma products and platforms. The firm emphasizes the creation of value through the formation and management of innovative life science companies, rather than traditional venture capital investments in existing companies.
Value and support
UpStart Life Sciences Capital offers mentorship, access to a network of industry experts, and support in the formation and management of innovative life science companies.
Additional public guidance
Q: What types of companies does UpStart invest in? A: UpStart primarily invests in seed and early-stage healthcare companies. Q: How does UpStart differentiate itself from traditional venture capital firms? A: UpStart focuses on company formation from university-derived technology, emphasizing the creation of new ventures rather than investing in existing companies.
Terms and economics
- Indicative investment
- $100,000,000
Availability
- Application state
- Not published
Focus and fit
- Stages
- Seed · Pre-seed
- Regions
- North AmericaUnited States
Alumni and track record
Alumni context
Notable alumni companies include Sera Prognostics, Inc., a preterm birth predictor based on serum proteomics; MedCatheters, Inc.; Q Therapeutics; and Elute, Inc., which specializes in drug delivery systems.
Common questions
What to know about UpStart Life Sciences Capital
Upseed classifies UpStart Life Sciences Capital under the Venture Studio organization type. Its current public profile includes funder and program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 28, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.